Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Colorectal Carcinoma Metastatic in the Liver: early-phase trial registry
1 of 3 indexed Colorectal Carcinoma Metastatic in the Liver trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Colorectal Carcinoma Metastatic in the Liver: 3 US clinical trials tracked, 1 recruiting.
Colorectal Carcinoma Metastatic in the Liver is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Brown University, running 1 of these trials.
Enrollment posture brief
Registry condition colorectal-carcinoma-metastatic-in-the-liver
OPEN 1 | RECR 33% | LATE 0 | EARLY 3 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Colorectal Carcinoma Metastatic in the Liver lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Colorectal Carcinoma Metastatic in the Liver on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Colorectal Carcinoma Metastatic in the Liver is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
Brown University
NCT06555133
Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer
M.D. Anderson Cancer Center
NCT03203525
An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer
City of Hope Medical Center
NCT03993327
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Colorectal Carcinoma Metastatic in the Liver records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Colorectal Carcinoma Metastatic in the Liver trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Colorectal Carcinoma Metastatic in the Liver page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Colorectal Carcinoma Metastatic in the Liver trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Brown University sponsors the most Colorectal Carcinoma Metastatic in the Liver trials on record, review their full trial history before evaluating a specific study. See Brown University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Colorectal Carcinoma Metastatic in the Liver condition card totals 3 registered trials; most-linked intervention Iodine I 124 Monoclonal Antibody M5A; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.